Foghorn Therapeutics Inc. (FHTX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:12PM EDT. Market open.
| Previous close | 6.00 |
| Open | 5.96 |
| Bid | 6.01 x 100 |
| Ask | 6.14 x 100 |
| Day's range | 5.96 - 6.16 |
| 52-week range | 2.70 - 9.97 |
| Volume | |
| Avg. volume | 89,669 |
| Market cap | 259.772M |
| Beta (5Y monthly) | 3.15 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.20 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.75 |
GlobeNewswireFoghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (“Foghorn”) (Nasdaq: FHTX) today announced the pricing of a registered direct offering of 12,743,039 shares of its common stock at a price of $5.51 per share, before underwriting discounts and commissions, and in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 7,220,794 shares of its common stock at a price of $5.5099 per pre-funded warrant, which represents the per share
Simply Wall St.Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target
Last week, you might have seen that Foghorn Therapeutics Inc. ( NASDAQ:FHTX ) released its quarterly result to the...
Simply Wall St.Foghorn Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Foghorn Therapeutics ( NASDAQ:FHTX ) First Quarter 2024 Results Key Financial Results Revenue: US$5.05m (down 4.9% from...
© 2024 Yahoo. All rights reserved.